Home / Funds / Citadel Securities (Europe) Limited
Citadel Securities (Europe) Limited
The short positions this fund discloses today, across every market.
15 open positions
5 Markets
August 12, 2026 Last disclosure
549300WTVI4KO4GEJN54 LEI
| Issuer | Market | % of capital | Since |
|---|---|---|---|
| Envipco Holding N.V. | Norway | 0.81% | August 12, 2026 |
| Avantium N.V. | Netherlands | 0.79% | August 3, 2026 |
| AB Science | France | 0.76% | August 10, 2026 |
| Nordic Mining | Norway | 0.72% | August 12, 2026 |
| SMAG Mobile Antenna Masts AG | Germany | 0.72% | August 7, 2026 |
| Alfen N.V. | Netherlands | 0.70% | August 12, 2026 |
| Nobia AB | Sweden | 0.69% | August 6, 2026 |
| SynAct Pharma AB | Sweden | 0.69% | August 12, 2026 |
| 2020 Bulkers | Norway | 0.68% | August 12, 2026 |
| LA Francaise de L'Energie | France | 0.60% | August 11, 2026 |
| Sensorion | France | 0.59% | August 5, 2026 |
| Amoeba | France | 0.58% | July 29, 2026 |
| Euroapi | France | 0.55% | July 30, 2026 |
| Roctool | France | 0.55% | August 11, 2026 |
| TeamViewer SE | Germany | 0.54% | July 30, 2026 |
History of disclosures
| Date | Issuer | Market | % of capital | End of publication |
|---|---|---|---|---|
| February 28, 2025 | Adocia | France | 0.49% | March 4, 2025 |
| February 27, 2025 | Ebusco Holding N.V. | Netherlands | 0.79% | still open |
| February 26, 2025 | Capital B | France | 0.68% | March 26, 2025 |
| February 26, 2025 | Ebusco Holding N.V. | Netherlands | 0.61% | still open |
| February 25, 2025 | Capital B | France | 0.74% | March 26, 2025 |
| February 18, 2025 | Solutions 30 SE | France | 0.35% | February 20, 2025 |
| February 17, 2025 | Capital B | France | 0.80% | March 26, 2025 |
| February 17, 2025 | Argeo ASA | Norway | 0.54% | February 18, 2025 |
| February 17, 2025 | Adocia | France | 0.52% | March 4, 2025 |
| February 14, 2025 | Capital B | France | 0.77% | March 26, 2025 |
| February 14, 2025 | Solutions 30 SE | France | 0.57% | February 20, 2025 |
| February 14, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.49% | still open |
| February 13, 2025 | Median Technologies | France | 0.77% | March 31, 2025 |
| February 13, 2025 | Capital B | France | 0.60% | March 26, 2025 |
| February 12, 2025 | Capital B | France | 0.57% | March 26, 2025 |
| February 12, 2025 | Moberg Pharma AB (publ) | Sweden | 0.53% | still open |
| February 11, 2025 | Median Technologies | France | 0.65% | March 31, 2025 |
| February 10, 2025 | Median Technologies | France | 0.70% | March 31, 2025 |
| February 6, 2025 | Median Technologies | France | 0.62% | March 31, 2025 |
| January 29, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.57% | still open |
| January 27, 2025 | Kalray | France | 0.47% | January 29, 2025 |
| January 24, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.62% | still open |
| January 23, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.71% | still open |
| January 22, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.67% | still open |
| January 15, 2025 | Kalray | France | 0.69% | January 29, 2025 |
| January 14, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.79% | still open |
| January 14, 2025 | Kalray | France | 0.71% | January 29, 2025 |
| January 13, 2025 | Kalray | France | 0.69% | January 29, 2025 |
| January 13, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.60% | still open |
| January 10, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.57% | still open |
| January 9, 2025 | Adocia | France | 0.48% | January 13, 2025 |
| January 8, 2025 | Solutions 30 SE | France | 0.62% | February 20, 2025 |
| January 6, 2025 | Kalray | France | 0.80% | January 29, 2025 |
| January 6, 2025 | Solutions 30 SE | France | 0.58% | February 20, 2025 |
| January 2, 2025 | Kalray | France | 0.62% | January 29, 2025 |
| January 2, 2025 | Adocia | France | 0.58% | January 13, 2025 |
| January 2, 2025 | Vivoryon Therapeutics N.V. | Netherlands | 0.47% | still open |
| December 30, 2024 | Adocia | France | 0.67% | January 13, 2025 |
| December 30, 2024 | Vivoryon Therapeutics N.V. | Netherlands | 0.58% | still open |
| December 27, 2024 | Kalray | France | 0.87% | January 29, 2025 |
| December 27, 2024 | Vivoryon Therapeutics N.V. | Netherlands | 0.61% | still open |
| December 20, 2024 | Adocia | France | 0.70% | January 13, 2025 |
| December 19, 2024 | Kalray | France | 0.92% | January 29, 2025 |
| December 19, 2024 | Adocia | France | 0.63% | January 13, 2025 |
| December 12, 2024 | Kalray | France | 0.80% | January 29, 2025 |
| December 11, 2024 | Ebusco Holding N.V. | Netherlands | 0.48% | still open |
| December 10, 2024 | Adocia | France | 0.71% | January 13, 2025 |
| December 9, 2024 | Vivoryon Therapeutics N.V. | Netherlands | 0.79% | still open |
| December 9, 2024 | Kalray | France | 0.72% | January 29, 2025 |
| December 9, 2024 | Solutions 30 SE | France | 0.61% | February 20, 2025 |
The funds short on the same companies
- WorldQuant, LLC 2 companies in common
- AQR Capital Management, LLC 1 company in common
- Citadel Advisors LLC 1 company in common
- Connor, Clark & Lunn Investment Management Ltd. 1 company in common
- GSA Capital Partners LLP 1 company in common
- Millennium Capital Partners LLP 1 company in common
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Citadel Securities (Europe) Limited, data as at August 12, 2026, https://www.quivad.com/detenteur/citadel-securities-europe-limited?page=9